Compare NetEase Inc (NTES) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetEase Inc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? NetEase Inc trades at $124.32 (market cap $76.09B), while Nuvation Bio Inc. Class A Common Stock trades at $5.01 (market cap $1.74B). The key difference: NetEase Inc is far larger — about 43.7× Nuvation Bio Inc. Class A Common Stock's market cap, and NetEase Inc pays a 2.45% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NetEase Inc for 73 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| NTES | NUVB | |
|---|---|---|
Market Cap | $76.09B | $1.74B |
Volume | 486,447 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $152.85 | $9.54 |
52-Week Low | $109.26 | $3.41 |
Typical Hold Time | 73 Days | 1 Days |
Enterprise Value | $51.81B | $1.33B |
Dividend Yield | 2.45% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTES trades at $124.20, up 2.98% today, with a neutral technical signal and mixed earnings history. The company reported Q2 2026 revenue growth of 8% year-over-year to $4.4 billion, though EPS missed expectations. Strong fundamentals include a 27.88% net income margin and robust cash flow from operations of $50.74 billion in 2025. Recent news highlights focus on gaming performance and AI investments.
Outlook remains positive with an 81.82% analyst buy rating and a $168.00 consensus price target, implying significant upside. Risks include earnings volatility and competitive pressures in the gaming sector. The stock presents a value opportunity given its reasonable P/E of 15.92 and strong balance sheet with $137.58 billion in cash.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
